
Press Release|Articles|March 8, 2024
Camber Pharmaceuticals Launches Generic Vascepa®
Camber Pharmaceuticals is pleased to announce the addition of Icoapent Ethyl Capsules to its current portfolio.
Advertisement
Camber Pharmaceuticals is pleased to announce the addition of Icoapent Ethyl Capsules to its current portfolio.
Icosapent Ethyl Capsules are an ethyl ester of eicosapentaenoic acid (EPA) indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥ 500 mg/dL) hypertriglyceridemia.
Icosapent Ethyl Capsules are available in:
- 0.5 gram - 240 count bottles
- 1 gram - 120 count bottles
To find out more about Icosapent Ethyl Capsule, please visit
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Beyond Cost Avoidance: Advancing Unit-Level Pharmaceutical Economics in Health Systems
2
Pharmacist Care Gets BP Patients to Goal Faster, Safer
3
Ivonescimab Significantly Extends OS Over Pembrolizumab in PD-L1-Positive Advanced NSCLC
4
FDA Approves Apitegromab-mstn, First Muscle-Targeted SMA Therapy
5


































































































